"Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we help pharma and biotech companies get new therapies to patients, fast."

During the past decade, SeaView Research, Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SeaView Research, Inc." #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "ViiV Healthcare" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SeaView Research, Inc." are "Healthy" (2 trials), "Neutropenia (Low White Blood Cell Count)" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetes Mellitus, Type II" (1 trials). Many other conditions were trialed in "SeaView Research, Inc." in a lesser frequency.

Most popular intervention types in "SeaView Research, Inc." are "Drug" (9 trials), "Biological" (5 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ranolazine" (3 trials), "Cenicriviroc" (2 trials), "Filgrastim Hospira (US)" (2 trials) and "2 POMx Capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "SeaView Research, Inc." are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SeaView Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in SeaView Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SeaView Research, Inc., 13 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".